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Abstract L-Cysteinyl-o-valine was isolated from incubations of 
t-glutamate, L-cysteine and L-valine with ~-L-(a-aminoadipoyl)- 
t-cysteinyl-o-valine synthetase and identified by ~H NMR and 
electrospray ionization MS. This is entirely consistent with our 
prior proposal (Shine, C.-Y., Baldwin, J.E., Byford, M.F., 
Sobey, W.J. and Schofield, C.J. (1995) FEBS Lett. 358, 97-100) 
that the a-peptide bond between eysteine and valine is formed 
before the ~-peptide bond between tx-aminoadipate and cysteine. 
The inclusion of L-glutamate, an analogue of L-ct-aminoadipate, 
did not result in a detectable amount of tripeptide product, but 
did increase apparent yields of L-cysteinyl-~-valine. Conceivably, 
formation of the L-glutamyladenylate stimulates ynthesis of the 
cysteinyl-valine dipeptide indirectly via a conformational change 
in the enzyme. 
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I. Introduction 
A single multifunctional enzyme, ACV synthetase, catalyses 
'he biosynthesis of J-L-(cz-aminoadipoyl)-L-cysteinyl-D-valine 
ACV), the common precursor of the penicillin and cepha- 
osporin antibiotics. It is evident on the basis of several proper- 
~ies of the enzyme and sequence identity with other peptide 
~ynthetases that it is a representative of this class of enzyme 
1-4]. A general 'thiol template' mechanism has been proposed 
"or the peptide synthetases [5] in which the carboxyl groups of 
~:he substrate amino acids are activated by formation of their 
~'espective aminoacyladenylates [1,6] and the aminoacyl groups 
are transferred to an enzyme-bound thiol. The thiol template 
mechanism also invokes the translocation f the enzyme-bound 
amino acid thioesters and the dipeptide intermediate by an 
indeterminate number of 4'-phosphopantetheine cofactors [5]. 
l'he proposed thiol template mechanism for the synthesis of 
ACV postulates the formation of the peptide bond between the 
&carboxyl of L-~-aminoadipate and the amino group of L- 
cysteine prior to that formed between L-cysteine and valine. 
Since ACV synthetase is relatively small (420 kDa, [4]) com- 
pared with most other members of the peptide synthetase fam- 
ily and catalyses comparatively few reactions, it is a useful 
model system for non-ribosomal peptide synthesis. 
Recently, we reported the isolation of two diastereoisomeric 
dipeptides, L-(O-methylserinyl)-L-valine and L-(O-methyl- 
serinyl)-D-valine from incubations of ACV synthetase with L- 
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~-aminoadipate and the cysteine analogue k-O-methylserine 
and k-valine [7]. In this communication wereport he isolation 
of L-cysteinyl-D-valine tself from incubations of ACV synthe- 
tase with L-cysteine and e-valine. We propose this dipeptide is 
a 'shunt' product arising from the incomplete biosynthesis of
ACV in the absence of a-aminoadipate. Detection of this dipep- 
tide synthesized from natural substrates provides further evi- 
dence for a revised mechanism for ACV biosynthesis, n which 
the cysteinyl-valine amide bond is formed prior to the aminoad- 
ipoyl-cysteinyl amide bond, which had previously been sug- 
gested by results obtained using the cysteine analogue, O-meth- 
ylserine. 
2. Experimental 
2.1. General 
Enzyme preparation, ACV synthetase assays, ~H NMR (500 MHz) 
and electrospray ionization MS analyses were done as described in[6]. 
Yields of isolated cysteinyl-valine w re variable and dependent upon 
the enzyme preparation used. L-Cysteinyl-L-valine, L-cysteinyl-D-valine, 
L-J-(~-aminoadipoyl)-L-cysteine and L-(7-glutamyl)-L-cysteinyl-D-va- 
line were synthesized by standard solution-phase methods and their 
structures confirmed by spectroscopic analyses and electrospray ionisa- 
tion MS [8]. 
2,2. Enzymic preparation of L, D-eysteinyl-valine dipeptide 
Incubations (final volume: 1ml) typically contained MgCI2 (42 mM), 
L-cysteine (5raM), e-valine (5 mM), L-glutamate (5 mM), dithiothreitol 
(17 raM) and 100-150 pkat ACV synthetase in 50 mM Tris-HCl buffer 
pH 7.5. and were carried out for 16 h at 27°C. An equal volume of 
acetone was added and the precipitated protein was removed by centrif- 
ugation. The acetone was removed in vacuo and the residue dissolved 
in 0.8 ml of water. 
2.3. Isolation of L-cysteinyl-o-valine dipeptide and attempted isolation qf 
L-J- (Ot-aminoadipoyl)-L-eysteine d p ptide 
These protocols were developed using authentic synthetic standards 
of L-cysteinyl-D-valine a d e-J-(~-aminoadipoyl)-L-cysteine [8]. Th  en- 
zymic product L-cysteinyl-D-valine was isolated by reverse-phase 
h.p.l.c. (Hypersil Cls 4.6 x 250 mm) with 20 mM NH4HCO3 in 20% (v/v) 
methanol at 1 ml/min. Retention volume: 5.6 ml. Prior to analysis, it
was converted to the disulphide form, L-cystinyl-(D-valine)2, by bub- 
bling 02 through the fraction collected from the HPLC after adjustment 
of the pH to approximately 10. We were unable to detect formation of 
k-J-(c~-aminoadipoyl)-L-cysteine in a alogous incubations using L-cys- 
teine and e-~-aminoadipate. W  therefore experimentally established a 
detection limit for this dipeptide. Acetone supernatants (200 pl) from 
enzyme incubations obtained as detailed above were doped with au- 
thentic L-J-(~-aminoadipoyl)-L-cysteine at 0.016 I.~glpl. The acetone was 
removed in vacuo and the supernatant freeze-dried. The residue was 
dissolved in water and then loaded on to a reverse phase HPLC column 
(Hypersil C~s 4.6 x 250 mm). The mobile phase (A) was triethylamine 
hydrochloride (4.3 g/l) in 20 mM NH4H2PO4, pH 6.5. The modifier (B) 
was obtained by adding 10% (v/v) methanol to the mobile phase. The 
flow rate was 1 ml/min. Isocratic elution was employed for 3 min with 
solution A, and then 16 min with solution B. Retention volume of 
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L-tL(ct-aminoadipoyl)-L-cysteine: 6.5 ml. Contaminating salts in the 
sample from the first HPLC purification were removed by a second 
HPLC step (Hypersil C~8 4.6 x 250 mm). The flow rate was I ml/min 
and the mobile phase was 25 mM NH4HCO~. A peak could readily be 
detected in the HPLC chromatogram at the expected retention volume 
for d~-(~-aminoadipoyl)-L-cysteine, ind cating that a total yield 4 ,ug 
(<0.5% yield) of dipeptide could be detected by HPLC. We were 
unable to detect any such material in incubations of ACV synthetase 
with c~-aminoadipate and L-cysteine. 
2.4. Quantification of L-cysteinyl-o-valine dipeptide formation 
Incubations contained MgCI2 (35 raM), dithiothreitol (1 mM) cyste- 
ine (2 mM), valine (2 mM), 9% (v/v) glycerol, 33 nkat inorganic pyro- 
phosphatase, 0.5 pCi [3,4 3HI valine (2.3 TBq/mmol, Amersham), a
range of concentrations ofglutamate and 20-30 pkat ACV synthetase 
in a final volume of 300 pl. Reactions were initiated by addition of ATP 
to a final concentration f7 mM and proceeded for 2 h at 27°C. Control 
incubations contained active enzyme but either no ATP or no cysteine. 
The reactions were terminated by the addition of acetone to 40% by 
volume and the protein removed by centrifugation i  a microfuge. 
Sufficient 10 M NaOH was added to the recovered supernatants to raise 
the pH to approximately 10.02 was bubbled through the supernatants 
for 10 rain. The acetone was removed in vacuo and sufficient 10% (w/v) 
aq. trichloroacetic acid, containing 400/,tM cystine as carrier, was 
added to bring the volume of the residue back to that of the original 
incubation. Portions (250 ~1) of this were chromatographed on Porapak 
Q columns as previously described [1,6,9] The methanol eluate (10%) 
was taken for liquid scintillation counting. Background counts for the 
incubations done either in the absence of ATP or the absence of cysteine 
were very similar (< + 2.0%). 
3. Results 
The recent isolation of both L-O-methylserinyl-D-valine a d
L-O-methylserinyl-L-valine from incubations of ACV synthe- 
tase with L-~-aminoadipate, L-O-methylserine and L-valine 
prompted us to attempt o isolate cysteinyl-valine itself from 
incubations with the natural substrates L-cysteine and L-valine. 
Initially, incubations were carried out under the usual condi- 
tions used for the enzymic production of ACV [6]. Authentic 
ACV and cysteinyl-valine were difficult to separate under the 
conditions used so biosynthetic samples of ACV were collected 
and analysed by electrospray ionization m.s. No cysteinyl-val- 
ine was detected in the ACV fraction within the limits of the 
instrument. However, it is not possible to rule out entirely the 
production of cysteinyl valine (< 10% relative to ACV) under 
these conditions. In contrast, when L-~-aminoadipate was omit- 
ted from incubations, HPLC analysis revealed a peak at a 
similar etention volume to authentic cysteinyl-valine. IH NMR 
analysis indicated the presence of an isopropyl group in the 
putative product, but insufficient material was isolated from the 
incubation for unambiguous identification of the peptide. 
L-Glutamate is a substrate for the ATP-PPi exchange reac- 
tion catalysed by C. acremonium ACV synthetase [6], presuma- 
bly because it is an analogue of cz-aminoadipate. Wespeculated 
that inclusion of this analogue might enhance production of 
cysteinyl-valine by the enzyme. We could accrue no evidence 
for the production of y-glutamyl-cysteinyl-valine during our 
original attempts to synthesize novel tripeptides using ACV 
synthetase, indicating that this analogue is discriminated 
against in a step subsequent to activation as its aminoacylad- 
enylate [6]. Inclusion of 5 mM L-glutamate in the incubation 
mixture enhanced the production of the putative dipeptide 
product sufficiently such that a final yield of 50 (+ 5)/~g (5.5%) 
of L-cysteinyl-D-valine (analysed as L-cystinyl-(D-valine)2) could 
be isolated from the incubation. The yield was determined by 
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Fig. 1. Dependence of L-cysteinyl-o-valine dipeptide formation on L- 
glutamate concentration. The cysteinyl-[aH]valine dipeptide was con- 
verted to its disulphide form and isolated by Porapak Q chromatogra- 
phy as described in section 2. It was quantified by liquid scintillation 
counting. The values hown are the means of triplicate determinations. 
integration of the product resonances versus those of an exter- 
nal standard [(2,2',3,3')-[2H4]-(trimethylsilyl)p ropanoic acid] in 
the ~H NMR (500 MHz) spectrum. The identity of the dipeptide 
as the disulphide form of cysteinyl valine was further substan- 
tiated by electrospray ionization MS: m/z (MH+), % relative 
abundancies in parentheses, 438 (0) 439 (MH +, 100) 440 (25) 
441 (10) 442 (0). The stereochemistry of the recovered ipeptide 
was assigned by doping with an authentic standard. We were 
unable to detect any biosynthesis ofy-glutamyl-cysteinyl-valine 
during these xperiments despite the availability of an authentic 
standard. 
Incubations were also carried out using authentic L,D- and 
L,L-cysteinyl-valine (5 mM) and c~-aminoadipate (5 raM) with 
ACV synthetase. Since cysteinyl-valine and d-L-(c~-aminoadi- 
poyl)-L-cysteinyl-D-valine were poorly separated by the HPLC 
system used, the recovered cysteinyl-valine starting material, 
potentially containing ACV was analysed by both ~H NMR 
and electrospray ionization MS. No evidence for the produc- 
tion of ACV was accrued, indicating that neither L,D nor L,L 
cysteinyl-valine are substrates for peptide synthesis. However 
production of a small amount of d-L-(~-aminoadipoyl)-L-cys- 
teinyl-D-valine (< 5% that of recovered cysteinyl-valine) during 
these experiments cannot be ruled out. Neither L,D nor L,L 
cysteinyl-valine w re able to stimulate ATP-PP~ exchange, indi- 
cating no formation of dipeptide aminocyladenylates. 
The effect of L-glutamate on the production of L-cysteinyl-D- 
valine by ACV synthetase was quantified by modifying the 
assay for tripeptide formation [1,6,9] to detect L-cysteinyl-D- 
valine. We found by using ~H NMR analysis that L-cysteinyl- 
D-valine did not substantially bind to the Porapak Q resin in 
its thiol form. However, conversion of authentic L-cysteinyl-D- 
valine to its disulphide form, as expected, resulted in a sufficient 
increase in hydrophobicity o cause retention of the dipeptide 
on the Porapak Q column. We then measured the incorpora- 
tion of 3H from [3,4 3H] valine into L-cystinyl-(D-valine)2 at 
various concentrations of L-glutamate and saturating concen- 
trations of the other two amino acids. That there is a significant 
effect of L-glutamate concentration on the production of cys- 
teinyl-valine is evident (Fig. 1). 
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In contrast, when L-~-ct-aminoadipic a id and L-cysteine 
were incubated with ACV synthetase, we were unable to detect 
any L-~-(e-aminoadipoyl)-L-cysteine by on the HPLC, or by JH 
NMR analysis of the portion of the HPLC effluent expected 
to contain the dipeptide. Control experiments ( ee section 2), 
in.¢olving doping of acetone supernatants with authentic L-g-(Ct- 
aminoadipoyl)-L-cysteine dicated that a yield of <4 /lg 
(-0.5%) of dipeptide in the incubation would have been 
& tected in the expected portion of the HPLC chromatogram 
o~ the scale on which the incubations were carried out. The 
p, ,ssibility that inclusion of L-glutamate might also stimulate 
tte production of ACV and free L-~-(~-aminoadipoyl)-L-cyste- 
ire was investigated. Inclusion of L-glutamate in the routine 
a say for ACV synthesis led to significant inhibition of ACV 
fi rmation by the synthetase (Fig 2). Aspartate, which is not a 
sJ gnificant substrate for ATP-PP~ exchange [6], failed to inhibit 
,a CV formation at concentrations of up to 4 mM at which 
L glutamate inhibited ACV formation by approximately 85%. 
"I hese observations show that glutamate, but not aspartate, 
iJ hibits ACV formation, presumably by competing for the acti- 
ttion site for c~-aminoadipate. Since it is a reasonable assump- 
t an that any putative production of L-~-(ct-aminoadipoyl)-L- 
c ~steine must be by a related mechanism as the L-6-(ct-ami- 
~9adipoyl)-L-cysteine moiety found in the complete product 
/, CV, glutamate cannot enhance production of a hypothetical 
t .~-(~-aminoadipoyl)-L-cysteine intermediate, in contrast to its 
~,tvility to stimulate significantly L-cysteinyl-D-valine produc- 
t on. 
a.  D iscuss ion  
Recently, we proposed a revised mechanism for the biosyn- 
1 lesis of ACV as a result of our detection of the diastereoisom- 
t rs L-(O-methylserinyl)-L-valine a d L-(O-methylserinyl)-D-val- 
i ae as novel dipeptide products of ACV synthetase [7] (Scheme 
). We also discussed the implications of this observation for 
~e timing of peptide bond formation and the epimerisation of
l he valine residue during the catalytic ycle. The results sub- 
~.tantiate he proposal that epimerisation i  the 'peptide-bound' 
:.tate might be a common mechanism for this reaction catalyzed 
,y some of the peptide synthetases .g. actinomycin synthetase 
I, in which the D-enantiomer in the final product is not the 
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Fig. 2. Inhibition of ACV synthesis by L-glutamate. Various concentra- 
tions of L-glutamate were included in the assay for ACV synthesis [13]. 
Determinations of incorporation ofradiolabel were done in triplicate. 
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Scheme 1. Proposed mechanism for ACV synthetase. AAA: ct-ami- 
noadipate; (Xaa-AMP): aminoacyladenylate of amino acid Xaa. E --: 
covalently bound pantetheinate cofactor. Independent sites for the ami- 
noacyladenylation, epimerisation, and thioesterase partial reactions are 
shown boxed (dashed lines). Note thioester formation is shown as 
occurring at the dipeptide stage, but in fact may occur at amino acid 
or even tripeptide stages. 
N-terminal residue [10]. This is in contrast o e.g. tyrocidin 
synthesis [11], where the freely reversible conversion of L- to 
D-phenylalanine by a phenylalanine racemase occurs prior to 
synthesis of a peptide in which the D-phenylalanine is the N- 
terminal residue. A caveat of these results was that the use of 
a cysteine analogue might have grossly perturbed the normal 
enzyme reactions, and that detection of the production cys- 
teinyl-valine dipeptide analogues was a result of aberrant en- 
zyme function. 
In this paper we have clearly demonstrated that small but 
detectable amounts of e,D-cysteinyl-valine (but not L,e-cys- 
teinyl-valine) are produced by ACV synthetase in the absence 
of L<z-aminoadipate. Furthermore, this dipeptide was detected 
in solution as a 'shunt product', in the same manner as the 
O-methylserinylvaline products we identified previously and 
not as an enzyme-bound intermediate. It is noteworthy that 
inversion of the stereochemical configuration of the valinyl 
c~-centre is apparently complete in the case of the dipeptide 
produced from the natural substrates. This would indicate that 
the enzyme bound L-O-methylserinyl-L-valine is a less effective 
substrate for the epimerisation reaction than L-cysteinyl-L-val- 
ine. We also observed that production of L-cysteinyl-D-valine 
was significantly enhanced in the presence of k-glutamate; in
fact unequivocal identification of this dipeptide was not possi- 
ble with the amounts produced in the absence of L-glutamate. 
In contrast L-glutamate, but not L-aspartate, significantly inhib- 
ited the production of the tripeptide product ACV, indicating 
competition for the L-~-aminoadipate ctivation site by L-gluta- 
mate. This observation indicates that L-glutamate would be 
unable to stimulate the production of a putative e-8-(~-ami- 
noadipoyl)-L-cysteine termediate since this would be formed 
by the same mechanism as the L-8-(c~-aminoadipoyl)-L-cysteine 
portion of the complete tripeptide. A stimulatory effect of glu- 
tamate on the production of penicillins ascribed to activation 
of the then postulated L<z-aminoadipoyl-t.-cysteinyl sy thetase 
has been previously reported [12]. More intriguingly, the ob- 
served stimulation of formation of the L-cysteinyl-D-valine p p- 
tide bond by the ~-aminoadipate analogue glutamate might 
indicate a regulatory effect on the rate of production and/or 
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release of the dipeptide intermediate by the ~-aminoadipate 
activation site. Potentially, aminoacyladenylate formation at 
the ~-aminoadipate site might be required for efficient forma- 
tion of the L-cysteinyl-D-valine p ptide bond. Only relatively 
small amounts of dipeptide product (Fig. 1) were produced in 
the absence of exogenous L-glutamate. This basal activity might 
simply reflect adventitious weak activation at the ~-aminoadi- 
pate site by cysteine, valine, or trace amounts of amino acids 
resulting from degradation of ACV synthetase under the incu- 
bation conditions. Alternatively, there may be residual tightly- 
bound ~-aminoadipoyladenylate at this site. In contrast to cys- 
teine and valine, ~-aminoadipate is not a proteinogenic amino 
acid. Regulation of the production of the L,D cysteinyl-valine 
intermediate by L-~-aminoadipate might have physiological rel- 
evance, ensuring that there is minimal futile synthesis and re- 
lease of L,D cysteinyl-valine in the absence of L-~-aminoadipate. 
To our knowledge, there are no reports of the detection of L,D 
cysteinyl-valine in vivo as a natural product. 
In summary, although the kinetic viability of an enzyme- 
bound cysteinyl-valine intermediate has not yet been proved for 
the biosynthesis of ACV, the observation that ACV synthetase 
is capable of catalysing both the formation of the cysteinyl- 
valine peptide link and the C-terminal epimerisation of the 
valinyl residue (in the 'peptide-bound' state) strongly supports 
the proposal that the cysteinyl-valine bond is formed both be- 
fore epimerisation at the valinyl position and before the amide 
bond with L-~-aminoadipate (Scheme 1). 
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